Vascepa is a prescription medication used to treat high levels of triglycerides in the blood. The drug is manufactured by Amarin Pharma Inc. According to the FDA label [2], Vascepa is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (TG ≥ 500 mg/dL). However, there are no restrictions on the distribution of Vascepa mentioned in the sources provided.

Drugpatentwatch [1] lists the patent and exclusivity status of Vascepa, indicating that the drug has patent protection until 2030. The website also mentions that there are no regulatory exclusivities for the drug, which means that other companies may be able to manufacture and distribute generic versions of Vascepa.

The official Vascepa website [3] provides information on the availability of the drug. It states that Vascepa is available by prescription only and can be filled at most retail pharmacies. The website also offers a savings card for eligible patients to reduce the cost of their prescription.

In conclusion, there are no restrictions on the distribution of Vascepa mentioned in the sources provided. The drug is available by prescription and can be filled at most retail pharmacies. However, Vascepa is still under patent protection until 2030, which may limit the availability of generic versions of the drug.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf
[3] https://www.vascepa.com/